Tylenol Maximum Daily Dosage To Drop To 3,000mg Per Day From 4,000mg

Tylenol, whose active ingredient is acetaminophen, will now have a lower recommended daily dose, which is aimed at reducing the risk of accidental overdose, McNeil Consumer Healthcare, a Johnson & Johnson company announced today. The recommended daily maximum for Extra Strength Tylenol 500mg tablets will go down from 8 per day to 6 per day, […]

Autonomic Technologies Announces Positive Preliminary Findings For A Novel Device For The Treatment Of Severe Headache

Autonomic Technologies, Inc. (ATI), the developer of a novel miniaturized implantable system for severe headaches, today announced positive preliminary findings from a study evaluating the safety and efficacy of the company’s investigational neurostimulation system for the treatment of cluster headache. Jean Schoenen, M.D…
More: continued here

New Migraine Neurostimulation Treatment On The US Horizon?

St. Jude Medical says it is seeking European regulatory permission to sell a device that somewhat alleviates migraine headaches. Yes, “somewhat” as initial testing has fallen short of the FDA’s overall goals, but even so, a quarter of the group experienced a decrease in headaches. The future of the device in the U.S…
More: […]

Clinical Trial Data Demonstrating Benefit Of Neuromodulation For Chronic Migraine

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, has announced study results on the safety and efficacy of peripheral nerve stimulation (PNS) of the occipital nerve for the management of pain and disability associated with chronic migraine, a debilitating condition that affects millions worldwide…
More: continued here

The First Animal Model Of A Severe Form Of Migraine Indicates Increased Neuronal Excitability As A Possible Cause

Familial hemiplegic migraine is a rare and severe subtype of migraine with aura, an unusual sensory experience preceding the migraine attack. Researchers from the San Raffaele Scientific Institute in Milan, and CNR Institute of Neuroscience in Pisa, Italy, have developed a mouse model of Familial Hemiplegic Migraine type 2 (FHM2) and used it to investigate […]

Clinical Trial Data Demonstrating Benefit Of Neuromodulation For Chronic Migraine

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, has announced study results on the safety and efficacy of peripheral nerve stimulation (PNS) of the occipital nerve for the management of pain and disability associated with chronic migraine, a debilitating condition that affects millions worldwide…
More: continued here

The First Animal Model Of A Severe Form Of Migraine Indicates Increased Neuronal Excitability As A Possible Cause

Familial hemiplegic migraine is a rare and severe subtype of migraine with aura, an unusual sensory experience preceding the migraine attack. Researchers from the San Raffaele Scientific Institute in Milan, and CNR Institute of Neuroscience in Pisa, Italy, have developed a mouse model of Familial Hemiplegic Migraine type 2 (FHM2) and used it to investigate […]

The First Animal Model Of A Severe Form Of Migraine Indicates Increased Neuronal Excitability As A Possible Cause

Familial hemiplegic migraine is a rare and severe subtype of migraine with aura, an unusual sensory experience preceding the migraine attack. Researchers from the San Raffaele Scientific Institute in Milan, and CNR Institute of Neuroscience in Pisa, Italy, have developed a mouse model of Familial Hemiplegic Migraine type 2 (FHM2) and used it to investigate […]

Clinical Trial Data Demonstrating Benefit Of Neuromodulation For Chronic Migraine

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, has announced study results on the safety and efficacy of peripheral nerve stimulation (PNS) of the occipital nerve for the management of pain and disability associated with chronic migraine, a debilitating condition that affects millions worldwide…
More: continued here

Clinical Trial Data Demonstrating Benefit Of Neuromodulation For Chronic Migraine

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, has announced study results on the safety and efficacy of peripheral nerve stimulation (PNS) of the occipital nerve for the management of pain and disability associated with chronic migraine, a debilitating condition that affects millions worldwide…
More: continued here


Pay Less for Generic - : Pay Less for Generic
Reliable Prescriptions Online - : Reliable Prescriptions Online
RX Pills Pharmacy - Buy Drugs: RX pills pharmacy
Rx pharma online - : Rx pharma online
RX Pill Vault - Buy Drugs: Interested in buying Rx pills? Here is the link for you.
Drug views - : Drug views
Latest News...